Brfs prostate
Webrecurrence-free survival (BRFS), overall survival (OS), and prostate cancer-specific mortality (PCSM) in intermediate- and high-risk prostate cancer patients. Methods We retrospectively reviewed the clinical data of 338 intermediate- and high-risk prostate cancer patients treated with EBRT with ADT at our institution between 2000 and 2024. WebOnly two patients experienced late grade 3 toxicity of hematuria. Multivariate analysis revealed that BRFS was significantly favorable in patients with prostate-specific antigen (PSA) values <0.5 ng/mL at the initiation of SRT and pathological Gleason score not including Gleason grade 5.
Brfs prostate
Did you know?
WebSep 13, 2024 · The Behavioral Risk Factor Surveillance System (BRFSS) is the nation's premier system of health-related telephone surveys that collect state data about U.S. residents regarding their health-related risk … WebOverall, for localized prostate cancer HDR-BT boost, our data show no significant differences in bRFS, MFS, and OS between both source types. The non-significant trend to decreased 10 year - bRFS in the Co-60 cohort with an absolute difference of 9.9% ( p = .073) may be the result of differences in underlying disease and dosimetric characteristics.
WebThe investigated endpoints were biochemical relapse-free survival (BRFS), clinical relapse-free survival (CRFS), distant metastasis-free survival (DMFS), and prostate cancer-specific survival (PCSS). Different covariates were considered to investigate predictors of survival. WebWhen tertiary Gleason pattern (TGP5) and intraductal carcinoma of the prostate (IDC-P) were excluded, the HR value of the GG 4 group vs the GG 3 group increased from 1.15 (95% CI: 0.59–2.22) to 1.49 (95% CI: 0.72–3.10) and 1.36 (95% CI:0.65–2.83), respectively. Conclusions: This study is the first to validate the new 2014 ISUP grading ...
WebJun 8, 2016 · In the multivariate analysis only the PSA at first follow-up resulted a prognostic factor for bRFS and MFS. Patients with a value of PSA at first follow-up <0.7 ng/mL respect to those with PSA ≥0,7 ng/mL had a 5y-bRFS of 93.3 % vs. 57.5 %, 5y-MFS of 99.0 % vs. 78.9 % and 5y-LF of 5.8 % vs. 38.3 %. WebFeb 27, 2024 · There were no differences in BRFS or OS, as anticipated in the context of similarly low rates (~1%) of long-term prostate cancer-specific mortality across men with low-risk PC undergoing...
WebDec 12, 2024 · External-beam radiotherapy (RT) is an established modality for definitive management of localized prostate cancer (LPCa). 1 Despite promising results with dose-escalated RT, a substantial proportion of patients develop recurrence with prolonged follow-up. 2-5 This remains a major reason for addition of androgen-deprivation therapy (ADT) …
WebApr 19, 2024 · BRFS after PET-directed management is 60% at a median of 20 months after salvage therapy, and complete biochemical response may be achieved in up to a quarter of men. There is a growing body of... indian railways awe 22907WebPurpose: The effectiveness and safety of high dose brachytherapy as monotherapy (HDR-BRT-M) in prostate cancer is limited to retrospective studies. We performed a meta-analysis to summarize existing data and identify trends in biochemical recurrence-free survival (bRFS) and toxicity after HDR-BRT-M in patients with prostate cancer. indian railways annual report 2021-22WebNational Center for Biotechnology Information indian railways beddingWebFeb 1, 2024 · Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) detects prostate cancer recurrence at low PSA levels. Radiotherapy with dose escalation to the former prostate bed has been associated with improved biochemical recurrence-free survival (BRFS). Thus, we … indian railways aparWebSecondary outcomes included biochemical recurrence-free survival (bRFS), prostate cancer-specific survival (PCSS), and overall survival (OS). All statistical tests were two-sided. Results: Unsupervised hierarchical clustering of hallmark pathways demonstrated an immune-related tumor cluster. indian railways as a monopolyWebBackground: The purpose of this study was to determine whether a "high-risk" subpopulation of low-grade (Gleason score ≤6) prostate cancer defined by lower prostate-specific … location physical featuresWebPatients with intraprostatic (or in the prostate bed) recurrence were treated with 5 to 9 fractions (median dose of 30 Gy in 5 fractions) with the MRIdian® system. PSA level and toxicities were evaluated before treatment and at three, six and 12 months after treatment. ... The bRFS was defined as the time between the end of reirradiation and ... location pin drop image